Liver cancer cells use protein arginine methyltransferase PRMT1 to PHGDH and enhance its catalytic activity, thereby enhancing serine synthesis, reducing oxidative stress, and ultimately promoting HCC growth and malignant progression 48, 49. This evidence concerns the gene PRMT1 and hepatocellular carcinoma.